CN103719496B - A kind of leaves of Hawthorn lowering blood-fat and reducing weight health protection tea and preparation method thereof - Google Patents
A kind of leaves of Hawthorn lowering blood-fat and reducing weight health protection tea and preparation method thereof Download PDFInfo
- Publication number
- CN103719496B CN103719496B CN201310752943.5A CN201310752943A CN103719496B CN 103719496 B CN103719496 B CN 103719496B CN 201310752943 A CN201310752943 A CN 201310752943A CN 103719496 B CN103719496 B CN 103719496B
- Authority
- CN
- China
- Prior art keywords
- parts
- hawthorn
- leaves
- fat
- root
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000009917 Crataegus X brevipes Nutrition 0.000 title claims abstract description 63
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 title claims abstract description 63
- 235000009685 Crataegus X maligna Nutrition 0.000 title claims abstract description 63
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 title claims abstract description 63
- 235000009486 Crataegus bullatus Nutrition 0.000 title claims abstract description 63
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 title claims abstract description 63
- 235000009682 Crataegus limnophila Nutrition 0.000 title claims abstract description 63
- 235000004423 Crataegus monogyna Nutrition 0.000 title claims abstract description 63
- 235000002313 Crataegus paludosa Nutrition 0.000 title claims abstract description 63
- 235000009840 Crataegus x incaedua Nutrition 0.000 title claims abstract description 63
- 230000036541 health Effects 0.000 title claims abstract description 46
- 230000001603 reducing effect Effects 0.000 title claims abstract description 35
- 238000002360 preparation method Methods 0.000 title claims description 13
- 240000000171 Crataegus monogyna Species 0.000 title abstract 4
- 244000269722 Thea sinensis Species 0.000 title abstract 3
- 239000003814 drug Substances 0.000 claims abstract description 57
- 241000405414 Rehmannia Species 0.000 claims abstract description 21
- 241000050051 Chelone glabra Species 0.000 claims abstract description 20
- 244000246386 Mentha pulegium Species 0.000 claims abstract description 16
- 235000016257 Mentha pulegium Nutrition 0.000 claims abstract description 16
- 235000004357 Mentha x piperita Nutrition 0.000 claims abstract description 16
- 235000001050 hortel pimenta Nutrition 0.000 claims abstract description 16
- 241000112528 Ligusticum striatum Species 0.000 claims abstract description 15
- 239000002994 raw material Substances 0.000 claims abstract description 14
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 claims abstract description 12
- 240000006509 Gynostemma pentaphyllum Species 0.000 claims abstract description 12
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 claims abstract description 12
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 claims abstract description 12
- 241000521581 Millettia Species 0.000 claims abstract description 12
- 240000000249 Morus alba Species 0.000 claims abstract description 12
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 12
- 241000218989 Trichosanthes Species 0.000 claims abstract description 12
- 101800004637 Communis Proteins 0.000 claims abstract description 11
- 240000007164 Salvia officinalis Species 0.000 claims abstract description 11
- 235000005412 red sage Nutrition 0.000 claims abstract description 11
- 241001092040 Crataegus Species 0.000 claims description 59
- 241001122767 Theaceae Species 0.000 claims description 22
- 235000013616 tea Nutrition 0.000 claims description 22
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 13
- 229940079593 drug Drugs 0.000 claims description 12
- 239000000284 extract Substances 0.000 claims description 12
- 238000010438 heat treatment Methods 0.000 claims description 11
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 8
- 238000000108 ultra-filtration Methods 0.000 claims description 8
- 206010023126 Jaundice Diseases 0.000 claims description 7
- 239000008187 granular material Substances 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- 238000000605 extraction Methods 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 6
- 230000000844 anti-bacterial effect Effects 0.000 claims description 5
- 230000002829 reductive effect Effects 0.000 claims description 5
- 230000001954 sterilising effect Effects 0.000 claims description 5
- 244000025254 Cannabis sativa Species 0.000 claims description 4
- 240000007890 Leonurus cardiaca Species 0.000 claims description 4
- 239000003205 fragrance Substances 0.000 claims description 4
- 229910052742 iron Inorganic materials 0.000 claims description 4
- 238000007493 shaping process Methods 0.000 claims description 4
- 238000004659 sterilization and disinfection Methods 0.000 claims description 4
- 239000006228 supernatant Substances 0.000 claims description 3
- 235000015091 medicinal tea Nutrition 0.000 claims description 2
- 238000002791 soaking Methods 0.000 claims description 2
- 239000008280 blood Substances 0.000 abstract description 55
- 210000004369 blood Anatomy 0.000 abstract description 55
- 230000000694 effects Effects 0.000 abstract description 40
- 230000009471 action Effects 0.000 abstract description 12
- 230000000144 pharmacologic effect Effects 0.000 abstract description 11
- 230000017531 blood circulation Effects 0.000 abstract description 10
- 229930003935 flavonoid Natural products 0.000 abstract description 10
- 150000002215 flavonoids Chemical class 0.000 abstract description 10
- 235000017173 flavonoids Nutrition 0.000 abstract description 10
- 230000001737 promoting effect Effects 0.000 abstract description 9
- 241000196324 Embryophyta Species 0.000 abstract description 8
- 208000004880 Polyuria Diseases 0.000 abstract description 8
- 230000035619 diuresis Effects 0.000 abstract description 8
- 208000001953 Hypotension Diseases 0.000 abstract description 7
- 208000021822 hypotensive Diseases 0.000 abstract description 7
- 230000001077 hypotensive effect Effects 0.000 abstract description 7
- 206010021143 Hypoxia Diseases 0.000 abstract description 6
- 230000007954 hypoxia Effects 0.000 abstract description 6
- 239000001301 oxygen Substances 0.000 abstract description 6
- 229910052760 oxygen Inorganic materials 0.000 abstract description 6
- 230000036513 peripheral conductance Effects 0.000 abstract description 6
- 208000010110 spontaneous platelet aggregation Diseases 0.000 abstract description 6
- 230000001976 improved effect Effects 0.000 abstract description 4
- 230000004089 microcirculation Effects 0.000 abstract description 4
- 210000002966 serum Anatomy 0.000 abstract description 4
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 abstract description 3
- 244000192528 Chrysanthemum parthenium Species 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 24
- 201000010099 disease Diseases 0.000 description 23
- 238000011282 treatment Methods 0.000 description 21
- 230000008901 benefit Effects 0.000 description 19
- 206010012601 diabetes mellitus Diseases 0.000 description 18
- 235000019197 fats Nutrition 0.000 description 17
- 241000700159 Rattus Species 0.000 description 16
- 238000000034 method Methods 0.000 description 15
- 210000002216 heart Anatomy 0.000 description 13
- 208000031226 Hyperlipidaemia Diseases 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 208000002193 Pain Diseases 0.000 description 10
- FINHMKGKINIASC-UHFFFAOYSA-N Tetramethylpyrazine Chemical compound CC1=NC(C)=C(C)N=C1C FINHMKGKINIASC-UHFFFAOYSA-N 0.000 description 10
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 10
- 206010020772 Hypertension Diseases 0.000 description 9
- 241001465754 Metazoa Species 0.000 description 9
- 230000006870 function Effects 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 238000011161 development Methods 0.000 description 8
- 230000018109 developmental process Effects 0.000 description 8
- 235000005911 diet Nutrition 0.000 description 8
- 235000013305 food Nutrition 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 241000207925 Leonurus Species 0.000 description 7
- 206010030113 Oedema Diseases 0.000 description 7
- 208000027418 Wounds and injury Diseases 0.000 description 7
- 150000002632 lipids Chemical class 0.000 description 7
- 210000004204 blood vessel Anatomy 0.000 description 6
- 230000002218 hypoglycaemic effect Effects 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 206010007247 Carbuncle Diseases 0.000 description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 description 5
- 208000037093 Menstruation Disturbances Diseases 0.000 description 5
- 206010027339 Menstruation irregular Diseases 0.000 description 5
- IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 description 5
- 208000025865 Ulcer Diseases 0.000 description 5
- IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 description 5
- 229960003321 baicalin Drugs 0.000 description 5
- AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 description 5
- 210000001124 body fluid Anatomy 0.000 description 5
- 239000010839 body fluid Substances 0.000 description 5
- 230000000747 cardiac effect Effects 0.000 description 5
- 239000000496 cardiotonic agent Substances 0.000 description 5
- 229940107161 cholesterol Drugs 0.000 description 5
- 208000029078 coronary artery disease Diseases 0.000 description 5
- 210000004351 coronary vessel Anatomy 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 230000034994 death Effects 0.000 description 5
- 230000037213 diet Effects 0.000 description 5
- 208000001848 dysentery Diseases 0.000 description 5
- 230000002708 enhancing effect Effects 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 235000020828 fasting Nutrition 0.000 description 5
- 239000007789 gas Substances 0.000 description 5
- 208000014674 injury Diseases 0.000 description 5
- 230000003908 liver function Effects 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 230000005906 menstruation Effects 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 208000031225 myocardial ischemia Diseases 0.000 description 5
- 208000026435 phlegm Diseases 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 238000005057 refrigeration Methods 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 210000000813 small intestine Anatomy 0.000 description 5
- 230000035922 thirst Effects 0.000 description 5
- 231100000397 ulcer Toxicity 0.000 description 5
- 208000004998 Abdominal Pain Diseases 0.000 description 4
- 206010002383 Angina Pectoris Diseases 0.000 description 4
- 208000006820 Arthralgia Diseases 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 206010019233 Headaches Diseases 0.000 description 4
- 206010027514 Metrorrhagia Diseases 0.000 description 4
- 208000008589 Obesity Diseases 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 206010003119 arrhythmia Diseases 0.000 description 4
- 230000006793 arrhythmia Effects 0.000 description 4
- 230000003143 atherosclerotic effect Effects 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 210000000748 cardiovascular system Anatomy 0.000 description 4
- 235000012000 cholesterol Nutrition 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 231100000869 headache Toxicity 0.000 description 4
- 230000035764 nutrition Effects 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 235000020824 obesity Nutrition 0.000 description 4
- 210000003800 pharynx Anatomy 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- ZSJLQEPLLKMAKR-GKHCUFPYSA-N streptozocin Chemical compound O=NN(C)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O ZSJLQEPLLKMAKR-GKHCUFPYSA-N 0.000 description 4
- HNOSJVWYGXOFRP-UNPOXIGHSA-N (5r,8s,9s,10s,11s,14r)-11-hydroxy-4,4,8,10,14-pentamethyl-17-[(2r,4s,5r)-4,5,6-trihydroxy-6-methylheptan-2-yl]-1,2,5,6,7,9,11,12,15,16-decahydrocyclopenta[a]phenanthren-3-one Chemical compound C([C@@]12C)CC(=O)C(C)(C)[C@@H]1CC[C@@]1(C)[C@H]2[C@@H](O)CC2=C([C@@H](C[C@H](O)[C@@H](O)C(C)(C)O)C)CC[C@@]21C HNOSJVWYGXOFRP-UNPOXIGHSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- HNOSJVWYGXOFRP-UHFFFAOYSA-N Alisol A Natural products CC12CCC(=O)C(C)(C)C1CCC1(C)C2C(O)CC2=C(C(CC(O)C(O)C(C)(C)O)C)CCC21C HNOSJVWYGXOFRP-UHFFFAOYSA-N 0.000 description 3
- FXNFHKRTJBSTCS-UHFFFAOYSA-N Baicalein Natural products C=1C(=O)C=2C(O)=C(O)C(O)=CC=2OC=1C1=CC=CC=C1 FXNFHKRTJBSTCS-UHFFFAOYSA-N 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- 206010013954 Dysphoria Diseases 0.000 description 3
- 206010017553 Furuncle Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- ZSJLQEPLLKMAKR-UHFFFAOYSA-N Streptozotocin Natural products O=NN(C)C(=O)NC1C(O)OC(CO)C(O)C1O ZSJLQEPLLKMAKR-UHFFFAOYSA-N 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- UDFLTIRFTXWNJO-UHFFFAOYSA-N baicalein Chemical compound O1C2=CC(=O)C(O)=C(O)C2=C(O)C=C1C1=CC=CC=C1 UDFLTIRFTXWNJO-UHFFFAOYSA-N 0.000 description 3
- 229940015301 baicalein Drugs 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 230000035617 depilation Effects 0.000 description 3
- 230000000378 dietary effect Effects 0.000 description 3
- 208000001780 epistaxis Diseases 0.000 description 3
- 239000002024 ethyl acetate extract Substances 0.000 description 3
- YMTINGFKWWXKFG-UHFFFAOYSA-N fenofibrate Chemical compound C1=CC(OC(C)(C)C(=O)OC(C)C)=CC=C1C(=O)C1=CC=C(Cl)C=C1 YMTINGFKWWXKFG-UHFFFAOYSA-N 0.000 description 3
- 229960002297 fenofibrate Drugs 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 201000001421 hyperglycemia Diseases 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 206010022000 influenza Diseases 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 239000002398 materia medica Substances 0.000 description 3
- 229960004329 metformin hydrochloride Drugs 0.000 description 3
- OETHQSJEHLVLGH-UHFFFAOYSA-N metformin hydrochloride Chemical compound Cl.CN(C)C(=N)N=C(N)N OETHQSJEHLVLGH-UHFFFAOYSA-N 0.000 description 3
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin hydrochloride Natural products CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 231100000862 numbness Toxicity 0.000 description 3
- 239000002574 poison Substances 0.000 description 3
- 206010036067 polydipsia Diseases 0.000 description 3
- 238000010791 quenching Methods 0.000 description 3
- 235000002020 sage Nutrition 0.000 description 3
- 230000035807 sensation Effects 0.000 description 3
- 235000019615 sensations Nutrition 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 229960001052 streptozocin Drugs 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- MCSXGCZMEPXKIW-UHFFFAOYSA-N 3-hydroxy-4-[(4-methyl-2-nitrophenyl)diazenyl]-N-(3-nitrophenyl)naphthalene-2-carboxamide Chemical compound Cc1ccc(N=Nc2c(O)c(cc3ccccc23)C(=O)Nc2cccc(c2)[N+]([O-])=O)c(c1)[N+]([O-])=O MCSXGCZMEPXKIW-UHFFFAOYSA-N 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 2
- 108010082126 Alanine transaminase Proteins 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 241000700199 Cavia porcellus Species 0.000 description 2
- 206010008631 Cholera Diseases 0.000 description 2
- 208000034657 Convalescence Diseases 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 208000005189 Embolism Diseases 0.000 description 2
- 208000004930 Fatty Liver Diseases 0.000 description 2
- 208000000616 Hemoptysis Diseases 0.000 description 2
- 206010019708 Hepatic steatosis Diseases 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 206010022998 Irritability Diseases 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 208000004078 Snake Bites Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- AIGAZQPHXLWMOJ-UHFFFAOYSA-N Tanshinone I Chemical compound C1=CC2=C(C)C=CC=C2C(C(=O)C2=O)=C1C1=C2C(C)=CO1 AIGAZQPHXLWMOJ-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 2
- 206010000269 abscess Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 239000003905 agrochemical Substances 0.000 description 2
- 230000000489 anti-atherogenic effect Effects 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 230000003542 behavioural effect Effects 0.000 description 2
- 208000002894 beriberi Diseases 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000003628 erosive effect Effects 0.000 description 2
- 239000000469 ethanolic extract Substances 0.000 description 2
- 201000005577 familial hyperlipidemia Diseases 0.000 description 2
- 208000010706 fatty liver disease Diseases 0.000 description 2
- 239000003337 fertilizer Substances 0.000 description 2
- 230000001605 fetal effect Effects 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 235000013376 functional food Nutrition 0.000 description 2
- 208000006750 hematuria Diseases 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 231100000240 steatosis hepatitis Toxicity 0.000 description 2
- QMGVPVSNSZLJIA-FVWCLLPLSA-N strychnine Chemical compound O([C@H]1CC(N([C@H]2[C@H]1[C@H]1C3)C=4C5=CC=CC=4)=O)CC=C1CN1[C@@H]3[C@]25CC1 QMGVPVSNSZLJIA-FVWCLLPLSA-N 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- 206010000242 Abortion threatened Diseases 0.000 description 1
- GBJKHDVRXAVITG-UNPOXIGHSA-N Alisol B Chemical compound O([C@@H]1[C@@H](O)C[C@@H](C)C=2CC[C@]3(C)[C@@]4(C)CC[C@H]5C(C)(C)C(=O)CC[C@]5(C)[C@@H]4[C@@H](O)CC3=2)C1(C)C GBJKHDVRXAVITG-UNPOXIGHSA-N 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 206010002368 Anger Diseases 0.000 description 1
- 244000252230 Artemisia stelleriana Species 0.000 description 1
- 241000132012 Atractylodes Species 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000001378 Carbon Tetrachloride Poisoning Diseases 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 241000233839 Commelina communis Species 0.000 description 1
- 244000247747 Coptis groenlandica Species 0.000 description 1
- 235000002991 Coptis groenlandica Nutrition 0.000 description 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 208000032928 Dyslipidaemia Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000053187 Glucuronidase Human genes 0.000 description 1
- 108010060309 Glucuronidase Proteins 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000017170 Lipid metabolism disease Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 208000027530 Meniere disease Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 241000218231 Moraceae Species 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- 206010050819 Musculoskeletal chest pain Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- QMGVPVSNSZLJIA-UHFFFAOYSA-N Nux Vomica Natural products C1C2C3C4N(C=5C6=CC=CC=5)C(=O)CC3OCC=C2CN2C1C46CC2 QMGVPVSNSZLJIA-UHFFFAOYSA-N 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 206010033307 Overweight Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 241000013557 Plantaginaceae Species 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037714 Quadriplegia Diseases 0.000 description 1
- 206010062237 Renal impairment Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 241001279009 Strychnos toxifera Species 0.000 description 1
- -1 TC) Chemical compound 0.000 description 1
- 229930183118 Tanshinone Natural products 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 208000005985 Threatened Abortion Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 244000290333 Vanilla fragrans Species 0.000 description 1
- 235000009499 Vanilla fragrans Nutrition 0.000 description 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
- 206010048245 Yellow skin Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 206010001093 acute tonsillitis Diseases 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 208000037883 airway inflammation Diseases 0.000 description 1
- 229930188824 alisol Natural products 0.000 description 1
- QMCLOHXDDPMAMI-UHFFFAOYSA-N alisol B Natural products CC(C)C(=O)C(O)CC(C)C1=C2CC(O)C3C4(C)CCC(=O)C(C)(C)C4CCC3(C)C2(C)CC1 QMCLOHXDDPMAMI-UHFFFAOYSA-N 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000002744 anti-aggregatory effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003579 anti-obesity Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000036523 atherogenesis Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000008344 brain blood flow Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 230000003177 cardiotonic effect Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 235000020965 cold beverage Nutrition 0.000 description 1
- 230000009989 contractile response Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- SXYIRMFQILZOAM-HVNFFKDJSA-N dihydroartemisinin methyl ether Chemical compound C1C[C@H]2[C@H](C)CC[C@H]3[C@@H](C)[C@@H](OC)O[C@H]4[C@]32OO[C@@]1(C)O4 SXYIRMFQILZOAM-HVNFFKDJSA-N 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 150000002168 ethanoic acid esters Chemical class 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 239000004459 forage Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000004362 fungal culture Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 238000010562 histological examination Methods 0.000 description 1
- 230000003118 histopathologic effect Effects 0.000 description 1
- 208000008025 hordeolum Diseases 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 229940095990 inderal Drugs 0.000 description 1
- 230000000053 inderal effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000000622 irritating effect Effects 0.000 description 1
- 230000005977 kidney dysfunction Effects 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000005976 liver dysfunction Effects 0.000 description 1
- 235000021142 long-term diet Nutrition 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- AQHHHDLHHXJYJD-UHFFFAOYSA-N propranolol Chemical compound C1=CC=C2C(OCC(O)CNC(C)C)=CC=CC2=C1 AQHHHDLHHXJYJD-UHFFFAOYSA-N 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000004089 psychotropic agent Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000000384 rearing effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 208000037921 secondary disease Diseases 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 229960005453 strychnine Drugs 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 230000001515 vagal effect Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 210000002385 vertebral artery Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 239000002918 waste heat Substances 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310752943.5A CN103719496B (en) | 2013-12-31 | 2013-12-31 | A kind of leaves of Hawthorn lowering blood-fat and reducing weight health protection tea and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310752943.5A CN103719496B (en) | 2013-12-31 | 2013-12-31 | A kind of leaves of Hawthorn lowering blood-fat and reducing weight health protection tea and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103719496A CN103719496A (en) | 2014-04-16 |
CN103719496B true CN103719496B (en) | 2015-09-30 |
Family
ID=50443990
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310752943.5A Active CN103719496B (en) | 2013-12-31 | 2013-12-31 | A kind of leaves of Hawthorn lowering blood-fat and reducing weight health protection tea and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103719496B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104663975A (en) * | 2014-11-27 | 2015-06-03 | 青岛申达高新技术开发有限公司 | Acanthopanax health tea for decreasing sugar and lipid and preparation method for acanthopanax health tea |
CN104605075A (en) * | 2015-01-20 | 2015-05-13 | 丁灏 | Osmanthus-scented hawthorn leaf and mint tea |
CN106266332A (en) * | 2016-09-27 | 2017-01-04 | 广西南宁隆吉维特生物科技有限公司 | A kind of oral liquid with effect for reducing blood fat |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1311032A (en) * | 2001-02-28 | 2001-09-05 | 华良药业有限公司 | Tea for reducing weight and lowering fat and its preparing method |
CN101911995A (en) * | 2010-08-11 | 2010-12-15 | 左权县馨源丰商贸有限公司 | Method for preparing fructus crataegi cuneatae leaf health-care tea |
CN102204602A (en) * | 2011-05-18 | 2011-10-05 | 徐杏昌 | Lipid-lowering and antihypertensive health tea and preparation method thereof |
CN102949618A (en) * | 2012-03-29 | 2013-03-06 | 叶国生 | Multifunctional diet tea |
CN103053748A (en) * | 2012-12-31 | 2013-04-24 | 青岛华仁信息技术开发有限公司 | Kudzu vine root fat-reducing sugar-reducing health-care tea and preparation method thereof |
-
2013
- 2013-12-31 CN CN201310752943.5A patent/CN103719496B/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1311032A (en) * | 2001-02-28 | 2001-09-05 | 华良药业有限公司 | Tea for reducing weight and lowering fat and its preparing method |
CN101911995A (en) * | 2010-08-11 | 2010-12-15 | 左权县馨源丰商贸有限公司 | Method for preparing fructus crataegi cuneatae leaf health-care tea |
CN102204602A (en) * | 2011-05-18 | 2011-10-05 | 徐杏昌 | Lipid-lowering and antihypertensive health tea and preparation method thereof |
CN102949618A (en) * | 2012-03-29 | 2013-03-06 | 叶国生 | Multifunctional diet tea |
CN103053748A (en) * | 2012-12-31 | 2013-04-24 | 青岛华仁信息技术开发有限公司 | Kudzu vine root fat-reducing sugar-reducing health-care tea and preparation method thereof |
Non-Patent Citations (1)
Title |
---|
降脂中药活性成分研究进展;梁燕玲等;《中国中医药现代远程教育》;20130623;第11卷(第12期);164-165页 * |
Also Published As
Publication number | Publication date |
---|---|
CN103719496A (en) | 2014-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103719497B (en) | A kind of gynostemma pentaphylla lowering blood-fat and reducing weight health protection tea and preparation method thereof | |
CN106215012A (en) | Prevention and treatment hypertension, hyperlipidemia, the teabag of hyperglycemia and processing method | |
CN103751707B (en) | Oral liquid of a kind of great burdock achene beauty treatment and eliminating spot and preparation method thereof | |
CN103749822B (en) | A kind of fruit of glossy privet hypertension and hyperlipemia health protection tea and preparation method thereof | |
CN103719494B (en) | A kind of great burdock achene defaecation health care tea for moistening intestines and preparation method thereof | |
CN103719492A (en) | Gynostemma pentaphylla liver protecting and nourishing health-care tea and preparation method thereof | |
CN104365943A (en) | Fructus sophorae tea with effect of reducing sugar and fat and preparation method thereof | |
CN102000164B (en) | Traditional Chinese medicine composition for treating psoriasis and preparation method thereof | |
CN103749824B (en) | A kind of Herb Gynostemmae Pentaphylli blood sugar lowering blood pressure depressing health tea and preparation method thereof | |
CN105124078A (en) | Gardenia blood-glucose-reducing and lipid-reducing healthcare tea and preparing method thereof | |
CN103041256B (en) | Chinese herb preparation for curing recurrent respiratory tract infection of children | |
CN103719496B (en) | A kind of leaves of Hawthorn lowering blood-fat and reducing weight health protection tea and preparation method thereof | |
CN103041257B (en) | Chinese materia medica preparation for curing high fever and respiratory tract infection of children | |
CN104304602A (en) | Pagoda tree fruit tea capable of softening blood vessels and preparation method thereof | |
CN104489172A (en) | Acanthopanax health tea for improving immunity and preparation method thereof | |
CN103783508A (en) | Buckwheat oral liquid for beauty treatment and freckle removal, and preparation method thereof | |
CN106237131A (en) | The Herba Taraxaci oral liquor of lowering blood-fat and reducing weight and oral liquid thereof | |
CN103041255B (en) | Chinese materia medica preparation for curing swollen sore throat and respiratory tract infection of children | |
CN103734425B (en) | A kind of leaves of Hawthorn hypoglycemic health protection tea and preparation method thereof | |
CN103549072B (en) | Vital energy-benefiting brain-boosting tea and preparation method thereof | |
CN105494780A (en) | Chinese hawthorn leaf health-care tea capable of protecting liver and lowering lipid and preparation method thereof | |
CN104206597B (en) | A kind of schisandra health care tea alleviating YIN-deficiency of the lung and kidney symptom and preparation method thereof | |
CN103520644B (en) | Traditional Chinese medicine composition used for treating phlegm stagnation type hyperlipidaemia and preparation method of composition | |
CN103041258B (en) | Chinese materia medica preparation for curing respiratory tract infection with poor appetite of children | |
CN109007161A (en) | A kind of gynostemma pentaphylla hypoglycemic blood pressure depressing health tea and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Feng Haidong Inventor after: Feng Hailing Inventor before: The inventor has waived the right to be mentioned |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: REQUEST NOT TO RELEASE THE NAME TO: PANG HAIDONG PANG HAILING |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180418 Address after: 710021 No. 3399, three road, grass beach, Xi'an economic and Technological Development Zone, Shaanxi Patentee after: SHAANXI CENTURY HEALTH PHARMACY CO., LTD. Address before: 266071 Shandong province Qingdao City Road No. 19 east red room unit 7 Patentee before: Qingdao Hengbo Instrument Co., Ltd. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Hawthorn leaf health-care tea for reducing fat and losing weight and preparation method thereof Effective date of registration: 20191010 Granted publication date: 20150930 Pledgee: Shaanxi cultural industry finance Company limited by guarantee Pledgor: SHAANXI CENTURY HEALTH PHARMACY CO., LTD. Registration number: Y2019610000039 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20201117 Granted publication date: 20150930 Pledgee: Shaanxi cultural industry finance Company limited by guarantee Pledgor: SHAANXI CENTURY HEALTH PHARMACY Co.,Ltd. Registration number: Y2019610000039 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: The invention relates to a hawthorn leaf lipid reducing and weight reducing health tea and a preparation method thereof Effective date of registration: 20210201 Granted publication date: 20150930 Pledgee: Shaanxi cultural industry finance Company limited by guarantee Pledgor: SHAANXI CENTURY HEALTH PHARMACY Co.,Ltd. Registration number: Y2021610000029 |